A randomized clinical trial to determine the efficacy of Affron, a standardised extract of Saffron (Crocus sativus) on mood and cognitive function in healthy adults over 4 weeks.

Integrated Health Group Pty. Ltd.0 sites150 target enrollmentOctober 2, 2014

Overview

No summary available.

Registry

who.int

Start Date

October 2, 2014

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

Integrated Health Group Pty. Ltd.

•1\. Adult males and females reporting having a low mood but:
•a) not diagnosed with a mood disorder such as depression, and
•b) assessed as not suffering from depression by the Beck Depression QOL at screening
•2\. Otherwise healthy; including BMI \<40\.
•3\. Written informed consent from the subject

•Exclusion Criteria
•Subjects will be excluded for any one of the following reasons:
•1\. Any condition which in the opinion of the investigator makes the subject unsuitable for inclusion
•2\. Known hypersensitivity to herbal drugs/nutritional supplement/ foods
•3\. Receiving/ prescribed coumadin (Warfarin), heparin, daltaparin, enoxaparin or other anticoagulation therapy
•4\. Diagnosed with hypertension and receiving/ prescribed antihypertensive medications
•5\. Diagnosed severe renal and/or hepatic insufficiency
•6\. Current or history of chronic alcohol and/or drug abuse
•7\. Participation in any other clinical trial during last 30 days
•8\. Simultaneous participation in another clinical trial